Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Almoslem

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutics|January 28, 2026
Translational Model to Predict Lung and Prostate Distribution of Levofloxacin in HumansEstevan Sonego Zimmermann, Teresa Dalla Costa, Brian Cicali, et al.
American Journal of Veterinary Research|September 27, 2018
Pharmacokinetics of tranexamic acid in healthy dogs and assessment of its antifibrinolytic properties in canine bloodKatie E Osekavage, Benjamin M Brainard, Selena L Lane, et al.
Journal of Clinical Pharmacology|November 28, 2023
Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of GestationMohammed Almoslem, Sanket D Shah, Valvanera Vozmediano, et al.
Pharmaceutics|October 28, 2023
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of PhenytoinLeyanis Rodriguez-Vera, Xuefen Yin, Mohammed Almoslem, et al.
Healthcare (Basel, Switzerland)|July 29, 2023
Public Anxiety, Attitudes, and Practices towards COVID-19 Infection in the Eastern Province of Saudi Arabia: A Cross-Sectional StudyMahmoud Mohamed Berekaa, Abdulaziz Abdulrahman AlMulla, Munthir Mohammed AlMoslem, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 19, 2024
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA regionMohammed S Alasmari, Salwa Albusaysi, Marwa Elhefnawy, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance SuppressionG L Drusano, Stephanie Rogers, David Brown, et al.
Plos One|February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validationsArnold Louie, Michael Neely, Sarah Kim, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2022
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister PhenotypeWalter Yamada, Sarah Kim, Mohammed Almoslem, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2020
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy RegimensG L Drusano, Sarah Kim, Mohammed Almoslem, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutics|January 28, 2026
Translational Model to Predict Lung and Prostate Distribution of Levofloxacin in HumansEstevan Sonego Zimmermann, Teresa Dalla Costa, Brian Cicali, et al.
American Journal of Veterinary Research|September 27, 2018
Pharmacokinetics of tranexamic acid in healthy dogs and assessment of its antifibrinolytic properties in canine bloodKatie E Osekavage, Benjamin M Brainard, Selena L Lane, et al.
Journal of Clinical Pharmacology|November 28, 2023
Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of GestationMohammed Almoslem, Sanket D Shah, Valvanera Vozmediano, et al.
Pharmaceutics|October 28, 2023
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of PhenytoinLeyanis Rodriguez-Vera, Xuefen Yin, Mohammed Almoslem, et al.
Healthcare (Basel, Switzerland)|July 29, 2023
Public Anxiety, Attitudes, and Practices towards COVID-19 Infection in the Eastern Province of Saudi Arabia: A Cross-Sectional StudyMahmoud Mohamed Berekaa, Abdulaziz Abdulrahman AlMulla, Munthir Mohammed AlMoslem, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 19, 2024
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA regionMohammed S Alasmari, Salwa Albusaysi, Marwa Elhefnawy, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance SuppressionG L Drusano, Stephanie Rogers, David Brown, et al.
Plos One|February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validationsArnold Louie, Michael Neely, Sarah Kim, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2022
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister PhenotypeWalter Yamada, Sarah Kim, Mohammed Almoslem, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2020
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy RegimensG L Drusano, Sarah Kim, Mohammed Almoslem, et al.
Pageof 2